Keenova Therapeutics plc - Common Stock, par value $0.01 per share (MNKTQ)

Historical Holders from Q2 2022 to Q4 2023

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
MNKTQ
Shares outstanding
39,518,605
Price from insider filings
$92.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Keenova Therapeutics plc - Common Stock, par value $0.01 per share (MNKTQ) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOLDENTREE ASSET MANAGEMENT LP 20% 7,946,176 Steven A. Tananbaum 31 Jul 2025
Silver Point Capital L.P. 12% +11% 4,702,714 +12% Silver Point Capital, L.P. 08 Dec 2025
MARATHON ASSET MANAGEMENT LP 7.7% 3,030,311 MARATHON ASSET MANAGEMENT GP, L.L.C. 30 Sep 2025
Hudson Bay Capital Management LP 6.3% 2,481,694 Hudson Bay Capital Management LP 31 Jul 2025
Hein Park Capital Management LP 4.9% -48% 1,955,827 +2.1% Hein Park Capital Management LP 31 Jul 2025
Flynn James E 4.1% 804,259 Deerfield Management Company, L.P. 31 Mar 2025

Institutional Holders of Keenova Therapeutics plc - Common Stock, par value $0.01 per share (MNKTQ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2023 Q4 0 $0 -$12,483 0
2023 Q3 146,419 $12,483 -$12,306,264 $0.0853 2
2023 Q2 10,483,926 $12,366,901 -$11,282,467 $1.18 35
2023 Q1 10,313,801 $75,218,046 -$870,603 $7.29 44
2022 Q4 10,324,766 $80,489,118 +$79,299,231 $7.75 45
2022 Q3 52,297 $889,000 +$10,000 $17.01 2
2022 Q2 48,731 $1,211,000 +$1,211,000 $24.86 2